Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
- PMID: 36096210
- PMCID: PMC9606833
- DOI: 10.1016/j.jcmgh.2022.08.009
Autotaxin, PPARs, and FGF21: An Eye Opener for Progressive Liver Disease?
Comment on
-
Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis.Cell Mol Gastroenterol Hepatol. 2022;14(5):1003-1023. doi: 10.1016/j.jcmgh.2022.07.012. Epub 2022 Aug 2. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35931383 Free PMC article.
Similar articles
-
A review of the studies on food-derived factors which regulate energy metabolism via the modulation of lipid-sensing nuclear receptors.Biosci Biotechnol Biochem. 2019 Apr;83(4):579-588. doi: 10.1080/09168451.2018.1559025. Epub 2018 Dec 20. Biosci Biotechnol Biochem. 2019. PMID: 30572788 Review.
-
Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.J Clin Endocrinol Metab. 2009 Sep;94(9):3594-601. doi: 10.1210/jc.2009-0111. Epub 2009 Jun 16. J Clin Endocrinol Metab. 2009. PMID: 19531592
-
Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis.Cell Mol Gastroenterol Hepatol. 2022;14(5):1003-1023. doi: 10.1016/j.jcmgh.2022.07.012. Epub 2022 Aug 2. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35931383 Free PMC article.
-
The role of peroxisome proliferator-activated receptors in healthy and diseased eyes.Exp Eye Res. 2021 Jul;208:108617. doi: 10.1016/j.exer.2021.108617. Epub 2021 May 16. Exp Eye Res. 2021. PMID: 34010603 Free PMC article. Review.
-
PPARs in liver physiology.Biochim Biophys Acta Mol Basis Dis. 2021 May 1;1867(5):166097. doi: 10.1016/j.bbadis.2021.166097. Epub 2021 Jan 29. Biochim Biophys Acta Mol Basis Dis. 2021. PMID: 33524529 Review.
References
-
- Honda Y, Imajo K, Kobayashi T, Kessoku T, Ogawa Y, Tomeno W, Yoneda M, Kobayashi N, Saito S, Nakajima A Autotaxin is a valuable biomarker for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease. Hepatol Res. 2019;49:1136–1146. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical